Cargando…
Low calcium dialysate combined with CaCO(3) in hyperphosphatemia in hemodialysis patients
This aim of this study was to observe the effects of the application of low calcium dialysate (LCD) combined with oral administration of CaCO(3) in the treatment of hyperphosphatemia, as well as blood Ca(2+), calcium-phosphate product (CPP), parathyroid hormone (PTH) and blood pressure in patients u...
Autores principales: | GAO, ZHUO, LUN, LI-DE, LI, XIN-LUN |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3702715/ https://www.ncbi.nlm.nih.gov/pubmed/23837063 http://dx.doi.org/10.3892/etm.2013.1067 |
Ejemplares similares
-
Calcium Acetate or Calcium Carbonate for Hyperphosphatemia of Hemodialysis Patients: A Meta-Analysis
por: Wang, Yong, et al.
Publicado: (2015) -
The Effects of Low Calcium Dialysate on Arterial Compliance and Vasoactive Substances in Patients with Hemodialysis
por: Yoo, Soo-Jeong, et al.
Publicado: (2004) -
Role of CaCO(3)° Neutral Pair in Calcium
Carbonate Crystallization
por: Genovese, Damiano, et al.
Publicado: (2016) -
Safety of Low-calcium Dialysate and its Effects on Coronary Artery Calcification in Patients Undergoing Maintenance Hemodialysis
por: Wen, Yang, et al.
Publicado: (2018) -
Impact of Dialysate Calcium Concentration on Clinical Outcomes in Incident Hemodialysis Patients
por: Kim, Hyung Wook, et al.
Publicado: (2015)